Investors

Overview

OpGen, Inc. is a precision medicine company harnessing the power of molecular diagnostics and informatics to help combat infectious disease. We are developing molecular information products and services for global healthcare settings, helping to guide clinicians with more rapid and actionable information about life threatening infections, improve patient outcomes, and decrease the spread of infections caused by multidrug-resistant microorganisms, or MDROs.

Shareholder Tools

Latest News
09.18.19
OpGen Provides update on Curetis Group’s R&D Collaboration
09.04.19
Curetis and OpGen Enter Into Definitive Agreement to Combine Businesses
08.07.19
OpGen Reports Second Quarter 2019 Financial Results and Provides Business Update

btn News

See All News

Upcoming Events
10.02 - 10.06.19
IDWeek MORE

btn Events

See all events